Literature DB >> 28799820

Arginine-modified dual emission photoluminescent nanocrystals for bioimaging at subcellular resolution.

Jun Zhang1, Jin Yan2, Qingchen Yang3, Yuwei Yan3, Shichao Li3, Lijuan Wang4, Chenyu Li4, Bo Lei2, Guang Yang5, Wangxiao He3.   

Abstract

Bioimaging at a subcellular resolution to label cytoplasm and nucleus in living cell by just one photoluminescent nanoparticle has great application potential in bioresearch, preclinical diagnosis, screening, and image-guided therapy of life-threatening diseases. Herein, we report a novel arginine (Arg) functionalized ultra-small lanthanide oxyfluoride nanocrystals (LaOF) for simultaneously targeted imaging cell cytoplasm and nucleus. As-prepared Arg-modified PAA capped LaOF: 45%Ce, 15%Tb nanocrystals (LaOF:Ce,Tb@PAA@Arg) possessed high water dispersibility, ultra-small size (∼5.7 nm) and double emissions (green and red) with high quantum yield (40%). Such functionalized nanocrystals presented high cellular biocompatibility and were successfully used to label living cells with very high contrast. These functionalized nanocrystals also exhibited significantly higher photostability and brightness as compared to commercial dyes. Such the ultra-small size, high photostability and intensity, double emissions, excellent biocompatibility and targeted ability, make as-prepared functionalized nanocrystals particularly promising for cellular and subcellular bioimaging applications.

Entities:  

Keywords:  Bioimaging; amino acid modified; cell labeling; dual emission photoluminescent; nanocrystal

Mesh:

Substances:

Year:  2017        PMID: 28799820     DOI: 10.1177/0885328217725203

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  5 in total

1.  A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.

Authors:  Wangxiao He; Jin Yan; Lijuan Wang; Bo Lei; Peng Hou; Wuyuan Lu; Peter X Ma
Journal:  Biomaterials       Date:  2019-03-21       Impact factor: 12.479

2.  Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.

Authors:  Fan Niu; Jin Yan; Bohan Ma; Shichao Li; Yongping Shao; Pengcheng He; Wanggang Zhang; Wangxiao He; Peter X Ma; Wuyuan Lu
Journal:  Biomaterials       Date:  2018-03-14       Impact factor: 12.479

3.  Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors.

Authors:  Weiming You; Fang Ma; Zhang Zhang; Jin Yan
Journal:  Pharmaceutics       Date:  2022-06-20       Impact factor: 6.525

4.  Assembling p53 Activating Peptide With CeO2 Nanoparticle to Construct a Metallo-Organic Supermolecule Toward the Synergistic Ferroptosis of Tumor.

Authors:  Jingmei Wang; Wenguang Yang; Xinyuan He; Zhang Zhang; Xiaoqiang Zheng
Journal:  Front Bioeng Biotechnol       Date:  2022-06-28

5.  Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery.

Authors:  Zhenyuan Bian; Jin Yan; Simeng Wang; Yijie Li; Yi Guo; Bohan Ma; Hao Guo; Zhijie Lei; Chun Yin; Yi Zhou; Min Liu; Kaishan Tao; Peng Hou; Wangxiao He
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.